Drug Type Gene therapy |
Synonyms |
Target |
Mechanism αvβ6 modulators(Integrin alpha-V/beta-6 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | NL | 18 May 2022 |